Source Natural Foods and Herbal Supplements Limited Stock
Stocks
531398
INE679C01027
Pharmaceuticals
|
Market Closed -
Bombay S.E.
06:02:21 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 106.90 INR | +0.42% |
|
-0.79% | -20.79% |
| Market Cap | 698M 7.31M 6.3M 5.9M 5.39M 10.15M 10.19M 70.05M 27.33M 353M 27.44M 26.84M 1.17B | P/E 2024 |
32.7x | P/E 2025 | 46.2x |
|---|---|---|---|---|---|
| Enterprise Value | 700M 7.33M 6.31M 5.92M 5.4M 10.18M 10.21M 70.23M 27.4M 353M 27.51M 26.91M 1.17B | EV / Sales 2024 |
1.86x | EV / Sales 2025 | 2.99x |
| Free-Float |
20.92% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.42% | ||
| 1 week | -0.79% | ||
| Current month | -5.02% | ||
| 1 month | +0.99% | ||
| 3 months | -2.86% | ||
| 6 months | -13.44% | ||
| Current year | -20.79% |
| 1 week | 102.15 | 121 | |
| 1 month | 100 | 121 | |
| Current year | 96.55 | 151.4 | |
| 1 year | 96.55 | 170 | |
| 3 years | 74.5 | 269.75 | |
| 5 years | 74.5 | 269.75 | |
| 10 years | 34.55 | 269.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 43 | 2013-12-30 | |
Yash Jain
CMP | Compliance Officer | - | - |
Ganga Prakash
AUD | Comptroller/Controller/Auditor | - | 2023-07-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 78 | 2008-06-29 | |
| Director/Board Member | 43 | 2013-12-30 | |
| Director/Board Member | 45 | 2017-06-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.42% | -0.79% | -21.60% | +19.84% | 7.2M | ||
| +0.35% | +0.93% | +20.41% | +72.21% | 48.2B | ||
| 0.00% | -0.33% | +53.39% | +119.44% | 39.97B | ||
| +0.15% | +6.34% | +21.40% | +89.62% | 12.43B | ||
| +0.25% | -0.61% | -10.44% | +15.16% | 12.03B | ||
| +0.19% | 0.00% | +29.35% | +150.00% | 9.35B | ||
| +0.07% | +3.80% | +30.19% | +51.59% | 7.75B | ||
| +2.24% | +8.50% | +30.72% | +232.96% | 7.43B | ||
| -1.06% | -0.55% | +42.72% | -11.99% | 7.22B | ||
| -0.53% | -1.53% | -36.09% | +17.02% | 5.3B | ||
| Average | +0.21% | +2.01% | +16.01% | +75.58% | 14.97B | |
| Weighted average by Cap. | +0.20% | +1.42% | +27.47% | +87.43% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 273M 2.86M 2.46M 2.31M 2.11M 3.97M 3.98M 27.38M 10.68M 138M 10.72M 10.49M 457M | 449M 4.7M 4.05M 3.8M 3.47M 6.53M 6.55M 45.06M 17.58M 227M 17.65M 17.26M 752M |
| Net income | 17.36M 182K 157K 147K 134K 252K 253K 1.74M 680K 8.77M 682K 667K 29.07M | 29.04M 304K 262K 245K 224K 422K 424K 2.91M 1.14M 14.66M 1.14M 1.12M 48.61M |
| Net Debt | -58.59M -613K -528K -495K -452K -852K -854K -5.88M -2.29M -29.57M -2.3M -2.25M -98.06M | 1.85M 19.31K 16.64K 15.61K 14.25K 26.84K 26.92K 185K 72.24K 932K 72.52K 70.94K 3.09M |
Employees
40
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | ₹106.90 | +0.42% | 15,968 |
| 26-08-27 | ₹106.45 | +0.42% | 7,044 |
| 26-08-26 | ₹106.00 | -2.12% | 540 |
| 26-08-25 | ₹108.30 | +2.61% | 4,396 |
| 26-08-24 | ₹105.55 | -2.04% | 2,823 |
- Stock Market
- Stocks
- 531398 Stock
Select your edition
All financial news and data tailored to specific country editions
















